SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 1,775.73 |
| Enterprise Value ($M) | 1,689.64 |
| Book Value ($M) | 318.83 |
| Book Value / Share | 3.41 |
| Price / Book | 5.57 |
| NCAV ($M) | 305.79 |
| NCAV / Share | 3.27 |
| Price / NCAV | 5.81 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.31 |
| Return on Assets (ROA) | -0.29 |
| Return on Equity (ROE) | -0.30 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 19.50 |
| Current Ratio | 19.50 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 327.00 |
| Assets | 340.04 |
| Liabilities | 21.20 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -114.36 |
| Net Income | -100.16 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -91.95 |
| Cash from Investing | 102.89 |
| Cash from Financing | 53.17 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Deep Track Capital, LP | 4.00 | -24.81 | |
| 13G/A | Viking Global Investors Lp | 9.70 | 39.69 | |
| 13G/A | Fmr Llc | 10.23 | -24.41 | |
| 13G/A | BlackRock Inc. | 4.10 | 5.99 | |
| 13G/A | Flynn James E | 5.25 | 13.87 | |
| 13G | Ra Capital Management, L.p. | 9.60 | ||
| 13D/A | Novo Holdings A/S | 7.40 | 4.49 | |
| 13D/A | Orbimed Advisors Llc | 17.30 | 3.18 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 122,633 | 1,005,857 | 12.19 | |
| 178,375 | 859,796 | 20.75 | |
| 111,686 | 418,975 | 26.66 | |
| 140,135 | 230,868 | 60.70 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ELVN – Enliven Therapeutics, Inc. | ENTA – Enanta Pharmaceuticals, Inc. |
| ERAS – Erasca, Inc. | EXEL – Exelixis, Inc. |
| FDMT – 4D Molecular Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io